Successful digoxin therapy of fetal supraventricular tachycardia in a triplet pregnancy.
BACKGROUND
Fetal supraventricular tachycardia is a rare complication of pregnancy associated with cardiac failure, hydrops, and fetal death. If no underlying cardiac defects are present, medical management with digoxin has been successful.


METHODS
A young woman with a triplet pregnancy presented at 23 17 weeks' gestation for routine Doppler auscultation which suggested fetal supraventricular tachycardia, confirmed by M-mode echocardiography. She was treated with oral digoxin for the remainder of her pregnancy with subsequent conversion of the tachycardic triplet to normal sinus rhythm with occasional premature atrial beats. After delivery, the triplet previously demonstrating supraventricular tachycardia had a normal sinus rhythm.


CONCLUSIONS
Digoxin might be used safely and successfully to treat fetal supraventricular tachycardia in multifetal pregnancies.
Jones
L M
LM
Department of Medical Education, Oakwood Hospital, Dearborn, Michigan 48123, USA. lisamjones44@hotmail.com
Garmel
S H
SH
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011272:Pregnancy, Multiple; D013617:Tachycardia, Supraventricular / Q000175:diagnosis / Q000188:drug therapy*; D014310:Triplets
D000889:Anti-Arrhythmia Agents; D004077:Digoxin